Case number 1:23-cv-00833
Azurity Pharmaceuticals, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 3, 2024 | 38 | NOTICE OF SERVICE of the file history for the asserted patents filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.(Zare, Maliheh) (Entered: 07/03/2024) (2) |
| Jul 3, 2024 | 37 | STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 7/3/2024. (dlw) (Entered: 07/03/2024) (26) |
| Jul 2, 2024 | 36 | NOTICE OF SERVICE of Plaintiffs' Initial Paragraph 4 Disclosures Identifying Zydus' Accused Products and Plaintiffs' Asserted Patents filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.(Zare, Maliheh) (Entered: 07/02/2024) (2) |
| Jul 2, 2024 | 35 | PROPOSED ORDER // Stipulated Protective Order by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. (Zare, Maliheh) Modified on 7/3/2024 (dlw). (Entered: 07/02/2024) (26) |
| Jul 1, 2024 | 34 | NOTICE OF SERVICE of Plaintiffs Rule 26(a)(1) Initial Disclosures filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.(Zare, Maliheh) (Entered: 07/01/2024) (2) |
| Jun 28, 2024 | 33 | NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Siew, Jennifer) (Entered: 06/28/2024) (2) |
| Jun 25, 2024 | N/A | SO ORDERED re 32 STIPULATION TO EXTEND TIME for the parties to serve initial disclosures under Federal Rule of Civil Procedure 26 to June 28, 2024. ORDERED by Judge Maryellen Noreika on 6/25/2024. (dlw) (Entered: 06/25/2024) (0) |
| Jun 25, 2024 | 32 | STIPULATION TO EXTEND TIME for the parties to serve initial disclosures under Federal Rule of Civil Procedure 26 to June 28, 2024 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 06/25/2024) (2) |
| Jun 18, 2024 | 31 | SCHEDULING ORDER: Joinder of Parties due by 10/30/2024. Amended Pleadings due by 10/30/2024. Fact Discovery completed by 12/13/2024. Opening Expert Reports due by 1/28/2025. Rebuttal Expert Reports due by 2/27/2025. Reply Expert Reports due by 3/13/2025. Expert Discovery due by 3/28/2025. Claim Construction Opening Brief served by 11/5/2024. Claim Construction Answering Brief served by 11/25/2024. Claim Construction Reply Brief served by 12/6/2024. Claim Construction Surreply Brief served by 12/13/2024. Joint Claim Construction Brief filed by 12/17/2024. A Markman Hearing is set for 1/7/2025 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 5/27/2025 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 6/2/2025 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 6/18/2024. (dlw) (Entered: 06/18/2024) (13) |
| Jun 14, 2024 | 30 | Letter to The Honorable Maryellen Noreika from Daniel M. Silver regarding Scheduling Order Dispute. (Attachments: # 1 Proposed Scheduling Order, # 2 Exhibit A)(Silver, Daniel) (Entered: 06/14/2024) (0) |
| May 15, 2024 | 29 | ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. A Bench Trial will be set to begin on 6/2/2025. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serve their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 5/15/2024. (dlw) (Entered: 05/15/2024) (0) |
| May 6, 2024 | 28 | NOTICE of Appearance by Maliheh Zare on behalf of Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited (Zare, Maliheh) (Entered: 05/06/2024) (2) |
| May 1, 2024 | 27 | NOTICE requesting Clerk to remove Alexandra Joyce as co-counsel. Reason for request: No Longer Counsel of Record. (Joyce, Alexandra) (Entered: 05/01/2024) (2) |
| Apr 25, 2024 | 26 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 04/25/2024) (3) |
| Apr 25, 2024 | 25 | ANSWER to 1 Complaint, and Affirmative Defenses by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) Modified on 4/25/2024 (mdb). (Entered: 04/25/2024) (19) |
| Mar 22, 2024 | N/A | SO ORDERED re 24 STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to April 25, 2024. As this is the parties' sixth request to extend time, the parties are cautioned that the Court may not grant any further extensions without a showing of good cause (Set/Reset Answer Deadlines: Zydus Lifesciences Limited answer due 4/25/2024; Zydus Pharmaceuticals (USA) Inc. answer due 4/25/2024). ORDERED by Judge Maryellen Noreika on 3/22/2024. (dlw) (Entered: 03/22/2024) (0) |
| Mar 22, 2024 | 24 | STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to April 25, 2024 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 03/22/2024) (2) |
| Feb 16, 2024 | N/A | Pro Hac Vice Attorney Bruce M. Wexler for Arbor Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/16/2024) (0) |
| Feb 15, 2024 | N/A | Pro Hac Vice Attorneys Christopher P. Hill, Chad J. Peterman, and Michael F. Werno for Arbor Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/15/2024) (0) |
| Feb 15, 2024 | N/A | Pro Hac Vice Attorney Sarah E. Spencer for Arbor Pharmaceuticals, LLC and Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00833-MN, 1:23-cv-01080-MN(mpb) (Entered: 02/15/2024) (0) |
| Feb 14, 2024 | N/A | SO ORDERED re 23 STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to March 26, 2024 (Set/Reset Answer Deadlines: Zydus Lifesciences Limited answer due 3/26/2024; Zydus Pharmaceuticals (USA) Inc. answer due 3/26/2024). ORDERED by Judge Maryellen Noreika on 2/14/2024. (dlw) (Entered: 02/14/2024) (0) |
| Feb 14, 2024 | 23 | STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to March 26, 2024 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 02/14/2024) (2) |
| Feb 12, 2024 | N/A | SO ORDERED re (24 in 1:23-cv-01080-MN, 21 in 1:23-cv-00833-MN) MOTION for Pro Hac Vice Appearance of Attorney Sarah E. Spencer filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 2/12/2024. (dlw) (Entered: 02/12/2024) (0) |
| Feb 12, 2024 | 22 | Pro Hac Vice Fee - Credit Card Payment received for Sarah E. Spencer. ( re 21 MOTION for Pro Hac Vice Appearance of Attorney Sarah E. Spencer )( Payment of $ 50, receipt number ADEDC-4335637).(Joyce, Alexandra) (Entered: 02/12/2024) (0) |
| Feb 12, 2024 | 21 | MOTION for Pro Hac Vice Appearance of Attorney Sarah E. Spencer - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc.. (Attachments: # 1 Certification for Sarah E. Spencer)(Joyce, Alexandra) (Entered: 02/12/2024) (0) |
| Feb 7, 2024 | 20 | Pro Hac Vice Fee - Credit Card Payment received for Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno. ( re 18 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno )( Payment of $ 200, receipt number ADEDC-4332769).(Silver, Daniel) (Entered: 02/07/2024) (0) |
| Dec 14, 2023 | 19 | STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to February 20, 2024 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 12/14/2023) (2) |
| Dec 14, 2023 | N/A | SO ORDERED re 19 STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to February 20, 2024 (Set/Reset Answer Deadlines: Zydus Lifesciences Limited answer due 2/20/2024; Zydus Pharmaceuticals (USA) Inc. answer due 2/20/2024). ORDERED by Judge Maryellen Noreika on 12/14/2023. (dlw) (Entered: 12/14/2023) (0) |
| Oct 31, 2023 | N/A | SO ORDERED re (11 in 1:23-cv-01080-MN, 18 in 1:23-cv-00833-MN) MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 10/31/2023. (dlw) (Entered: 10/31/2023) (0) |
| Oct 30, 2023 | 18 | MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, and Michael F. Werno - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc.. (Attachments: # 1 Certifications for Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno)(Joyce, Alexandra) (Entered: 10/30/2023) (0) |
| Oct 13, 2023 | N/A | SO ORDERED, re 17 STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to December 18, 2023. Set/Reset Answer Deadlines: Zydus Lifesciences Limited answer due 12/18/2023; Zydus Pharmaceuticals (USA) Inc. answer due 12/18/2023. Ordered by Judge Maryellen Noreika on 10/13/2023. (as) (Entered: 10/13/2023) (0) |
| Oct 13, 2023 | 17 | STIPULATION TO EXTEND TIME for Zydus to answer, move, or otherwise respond to Plaintiffs' Complaint to December 18, 2023 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 10/13/2023) (2) |
| Oct 6, 2023 | 16 | SO ORDERED, re 15 Stipulation and [Proposed] Order Dismissing Without Prejudice Defendant Zydus Worldwide DMCC and Amending Caption to Reflect Same. Party Zydus Worldwide DMCC terminated. Signed by Judge Maryellen Noreika on 10/6/2023. (mdb) (Entered: 10/06/2023) (2) |
| Oct 6, 2023 | 15 | STIPULATION and [Proposed] Order Dismissing Without Prejudice Defendant Zydus Worldwide DMCC and Amending Caption to Reflect Same by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) (Entered: 10/06/2023) (2) |
| Sep 29, 2023 | N/A | Pro Hac Vice Attorney Hannah J. Thomas, Jonathan B. Turpin, Emily L. Savas, and Michael J. Gaertner for Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., and Zydus Worldwide DMCC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 09/29/2023) (0) |
| Sep 27, 2023 | N/A | SO ORDERED re 14 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Emily L. Savas, Jonathan B. Turpin, and Hannah J. Thomas filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. ORDERED by Judge Maryellen Noreika on 9/27/2023. (dlw) (Entered: 09/27/2023) (0) |
| Sep 27, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, Emily L. Savas, Jonathan B. Turpin, and Hannah J. Thomas - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) (Entered: 09/27/2023) (8) |
| Sep 13, 2023 | 13 | SO ORDERED re 12 STIPULATION TO EXTEND TIME for Zydus USA and Zydus Lifesciences to answer, move, or otherwise respond to Plaintiffs' complaint to October 17, 2023 (Set/Reset Answer Deadlines: Zydus Lifesciences Limited answer due 10/17/2023; Zydus Pharmaceuticals (USA) Inc. answer due 10/17/2023). ORDERED by Judge Maryellen Noreika on 9/13/2023. (dlw) (Entered: 09/13/2023) (2) |
| Sep 13, 2023 | 12 | STIPULATION TO EXTEND TIME for Zydus USA and Zydus Lifesciences to answer, move, or otherwise respond to Plaintiffs' complaint to October 17, 2023 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Kraman, Pilar) (Entered: 09/13/2023) (2) |
| Aug 24, 2023 | N/A | SO ORDERED re 11 STIPULATION TO EXTEND TIME for Zydus USA to answer, move, or otherwise respond to Plaintiffs' Complaint to September 14, 2023 (Set/Reset Answer Deadlines: Zydus Pharmaceuticals (USA) Inc. answer due 9/14/2023). ORDERED by Judge Maryellen Noreika on 8/24/2023. (dlw) (Entered: 08/24/2023) (0) |
| Aug 24, 2023 | 11 | STIPULATION TO EXTEND TIME for Zydus USA to answer, move, or otherwise respond to Plaintiffs' Complaint to September 14, 2023 - filed by Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 08/24/2023) (2) |
| Aug 22, 2023 | N/A | Pro Hac Vice Attorney Zhiqiang Liu for Takeda Pharmaceutical Company Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 08/22/2023) (0) |
| Aug 22, 2023 | N/A | SO ORDERED, re 10 MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Jr. and Zhiqiang Liu filed by Takeda Pharmaceutical Company Limited. Ordered by Judge Maryellen Noreika on 8/22/2023. (as) (Entered: 08/22/2023) (0) |
| Aug 22, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Jr. and Zhiqiang Liu - filed by Takeda Pharmaceutical Company Limited. (Attachments: # 1 Certifications)(Silver, Daniel) (Entered: 08/22/2023) (0) |
| Aug 9, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 08/09/2023) (0) |
| Aug 7, 2023 | 9 | DECLARATION of Service on Zydus Pharmaceuticals (USA) Inc. by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. (Attachments: # 1 Exhibit A-B)(Silver, Daniel) Modified on 8/9/2023 (dlw). (Entered: 08/07/2023) (0) |
| Aug 2, 2023 | 8 | Summons Issued as to Zydus Lifesciences Limited on 8/2/2023; Zydus Pharmaceuticals (USA) Inc. on 8/2/2023; Zydus Worldwide DMCC on 8/2/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(apk) (Entered: 08/02/2023) (0) |
| Aug 2, 2023 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate The Master Bank of Japan, Ltd. for Takeda Pharmaceutical Company Limited filed by Takeda Pharmaceutical Company Limited. (apk) (Entered: 08/02/2023) (2) |
| Aug 2, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc. (apk) (Entered: 08/02/2023) (2) |
| Aug 2, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Arbor Pharmaceuticals, Inc. for Arbor Pharmaceuticals, LLC filed by Arbor Pharmaceuticals, LLC. (apk) (Entered: 08/02/2023) (2) |
| Aug 2, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,066,936 ;9,169,238 ;9,387,249. (apk) (Entered: 08/02/2023) (1) |
| Aug 2, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ANDA FORM. Date of Expiration of Patent: SEE ANDA FORM. (apk) (Entered: 08/02/2023) (2) |
| Aug 2, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 08/02/2023) (3) |
| Aug 2, 2023 | 1 | Complaint* (1) |
